CTI Acquires S2

CTI Clinical Trial and Consulting Services (CTI) has acquired S² Statistical Solutions, a health outcomes and health economics company. S² specializes in generating and interpreting evidence from large databases and then publishing it in peer-reviewed publications. S² partners with pharmaceutical, medical device, and diagnostic companies to provide outcome and economic analyses, models, visualization programs, systematic literature reviews, and meta-analyses. Dr. Candace Gunnarsson, the founder of S², will be joining CTI along with her entire team. Financial terms were not disclosed.

Lynn Fallon, executive vice president and president of Consulting Services at CTI, said, “The S² team members are incredibly accomplished with top-ranked scientists, health economists, and statisticians, and will join Dr. William Irish, CTI’s vice president of Health Outcomes and Biostatistics, as well as the rest of our team at CTI. This merger strengthens our service offerings from the early development stages of drugs and devices through Phase III and commercialization. Investors often require companies to build economic models to provide product valuation, even in early development. Health economics is also proving particularly important to the many orphan disease programs that CTI is leading.”